Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Commentary|Videos|October 30, 2023
Pediatric Disability and Poverty: A Symbiotic System
Author(s)Grace Halsey
Advertisement
"There is a very strong relationship between experiencing disability in childhood and living in poverty," observed Amy Houtrow, MD, PhD, MPH, in a recent interview with Patient Care.® Houtrow is engaged in research on the impact of socioeconomic disadvantage on a wide range of developmental issues in pediatric patients. She explains more in this short video.
Amy Houtrow, MD, PhD, MPH, is chief of pediatric rehabilitation medicine at the UPMC Children’s Hospital of Pittsburgh; endowed professor of physical medicine and rehabilitation and pediatrics at the University of Pittsburgh School of Medicine; and secretary of the Board of Governors of the American Academy of Physical Medicine and Rehabilitation.
Advertisement
Related to this article
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Investigational CagriSema produced 23.1% to 26.7% weight loss across menopause stages at 68 weeks, with improvements in cardiometabolic risk factors.
An EHR-integrated tool matched manual CKD and cardiovascular risk assessments in 60 patients and showed promise for improving risk-based kidney care in primary care.
TMS 2026: Nearly 67% of US women receiving elinzanetant achieved at least a 50% reduction in menopausal VMS frequency by week 12 in pooled phase 3 trial data.
TMS 2026: Only 21.7% of women initiated menopause hormone therapy, with significant racial disparities and low treatment persistence, a new study finds.
TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found.
JoAnn Pinkerton, MD, discusses new research she presented at The Menopause Society 2026 Annual Meeting on elinzanetant for menopausal vasomotor symptoms.
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Care in Primary Care: Closing Diagnosis and Treatment Gaps
2
Primary Care Lens: Atrial Fibrillation From Detection to Referral in Primary Care
3
CagriSema Cuts Weight Up to 27% Across Menopause Stages: TMS 2026
4
Night Sweats in Midlife Women: A Q&A With Cheryl Cox Kinney, MD
5